C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia

Annals of Hematology

Volumn 85, Issue 2, 2006, Pages 108-112

  Auewarakul, Chirayu ^a   Lauhakirti, Darat ^b   Promsuwicha, Orathai ^a   Munkhetvit, Chanya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acute leukemia; C kit receptor tyrosine kinase; CD117 expression; Predictive values; Thailand

Indexed keywords

CD45 ANTIGEN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; TYROSINE KINASE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THAILAND;

ACUTE DISEASE; ADULT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-KIT; THAILAND; TUMOR MARKERS, BIOLOGICAL;

EID: 30644469132     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-0039-3     Document Type: Article

References (27)

1. Kelly LM, Gilliland DG (2002) Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:179-198 10.1146/annurev.genom.3.032802.115046
2. Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 (7):2292-2302 10.1182/blood-2002-04-1199
3. Udomsakdi-Auewarakul C, PromsuwichaO, U-pratya Y, Tocharoentanaphol C, Patanapanyasat K, Issaragrisil S (2003) Immunophenotypic profile of adult acute myeloid leukemia (AML): Analysis of 267 cases in Thailand. Asian Pac J Allergy Immunol 21:153-160 15032399
4. 1)-positive and -negative Thai adult acute lymphoid leukemia. Int J Hematol 78:337-343 14686492
5. Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535-1548 15071128
6. Besmer P, Murphy JE, George PC, Qiu FH, Bergold PJ, Lederman L et al (1986) A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320(6061):415-421 10.1038/320415a0
7. Reilly JT (2003) Receptor tyrosine kinases in normal and malignant haematopoiesis. Blood Rev 17 4 241-248 10.1016/S0268-960X(03)00024-9
8. Linnekin D (1999) Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 31(10):1053-1074 10.1016/ S1357-2725(99)00078-3
9. Akin C, Metcalfe DD (2004) The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 114(1):13-19, quiz 20 10.1016/j.jaci.2004.04.046
10. Scheijen B, Griffin JD (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 21(21):3314-3333 10.1038/sj.onc.1205317
11. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J et al (1991) Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78 11 2962-2968 1720040
12. Chui CH, Lau FY, Yau KS, Lee FC, Chan LC, Cheng G (1997) Low frequency of c-kit expression and detection of an aberrant Kit message among Hong Kong Chinese myelogenous leukaemia patients. Cancer Lett 116(2):253-258 10.1016/S0304-3835(97)00195-X
13. Bene MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F et al (1998) The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). Blood 92(2):596-599 9657760
14. Nomdedeu JF, Mateu R, Altes A, Llorente A, Rio C, Estivill C et al (1999) Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Leuk Res 23(4):341-347 10.1016/S0145-2126(98)00185-4
15. Newell JO, Cessna MH, Greenwood J, Hartung L, Bahler DW (2003) Importance of CD117 in the evaluation of acute leukemias by flow cytometry. Cytometry B Clin Cytom 52(1):40-43 10.1002/cyto.b.10009
16. Wozniak J, Kopec-Szlezak J (2004) c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia. Cytometry B Clin Cytom 58(1):9-16 10.1002/cyto.b.10068
17. Uckan D, Hicsonmez G, Yetgin S, Gurgey A, Cetin M, Karaagaoglu E et al (2000) CD34/CD117 co-expression in childhood acute leukemia. Leuk Res 24(3):201-206 10.1016/S0145-2126(99)00183-6
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33 4 451-458 188440
19. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9(10):1783-1786 7564526
20. F Mitelman 1995 An international system for human cytogenetic nomenclature Karger Basel, Switzerland
21. M Buyse M Staquet R Sylvester 1992 Cancer clinical trials: Methods and practice Oxford University Press Oxford, UK
22. Orfao A, Ortuno F, de Santiago M, Lopez A, San Miguel J (2004) Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 58(1):62-71 10.1002/cyto.a.10104
23. Huh YO, Ibrahim S (2000) Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am 14(6):1251-1265 10.1016/S0889-8588(05)70185-4
24. Legrand O, Perrot JY, Baudard M, Cordier A, Lautier R, Simonin G et al (2000) The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood 96(3):870-877 10910899
25. Tsao AS, Kantarjian H, Thomas D, Giles F, Cortes J, Garcia-Manero G et al (2004) C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leuk Res 28(4):373-378 10.1016/j.leukres.2003.09.008
26. Gari M, Goodeve A, Wilson F et al (1999) C-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukemia. Br J Haematol 05:894-900 10.1046/j.1365-2141.1999.01449.x
27. Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20(6):1692-1703 10.1200/ JCO.20.6.1692